PFE-BUY++We are at interesting buy levels. The move down is overdone, and that is why a low RSI level. Strategy is BUY current $ 46 area and lower down again $ 43-44 and profit order at $ 52.50 for now. Longby peterbokma3
PFE still lower to go. Pfizer looks to test $50, and possibly the gap around 46~ if things get really ugly. Omicron is looking really promising as granting significant immunity after infection, which should reduce demand for further vaccinations. These vaccines companies have YEARS of covid priced into their stocks... Short side is getting a bit long in the tooth for new entries, however I am still holding 2/3rds of my puts across the board for these plays. We posted our short thesis in another thread www.tradingview.comShortby WLinvestmentUpdated 443
PFE | Shorting the Vaccine 💉My current position and play is marked on the chart. I am expecting more selling pressure to come in now that we closed below the nearest zone. Expectation is that PFE will head toward the next zone located at the bottom. I will be trailing my stop once PFE begins the bearish move. Shortby ChowskiPicassoUpdated 1
PFE-BUY strategyThere may be still little room lower, but it will not be a lot I feel. the DC suggest the lower move, and the stochastic is negative, but low level. Strategy BUY $ 44-45 area for a move back towards $ 55. Stop-loss let's say around $ 38 for now. Longby peterbokma224
PFE Long'sAll Long entry points on PFE: The best Long entry: $39.46 2nd: $41.93 3rd: $43.32 4th: $45.07 5th: $47.99 price is currently trading at this Bull zone, so there could be a bounce here, potentially back up to $52.90 before moving lower. All Exits: Best: $59.83 Get out when you want, whenever you're in profit. SL: $33.90 Risk: 15 - 20% This play assumes that price will move back up to $59 dollars at least. In the future Bull moves that Pfizer will make. Looking for another breakout to the upside. A repeat similar to the Bull move that happened at $39 and $41.90. Longby UnknownUnicorn7610931
Pfizer more to drop I see a 5 waves move up finished at $61 on 20th December, fallowed by an A-B-C standard correction. Using the guideline of equality A=C and the Trend Based Fibonacci extension Pfizer will drop till about 1 level or $41. This has support as well from $41 OCT 2021 level which is also the W4 level in the previous impulse movement. Disclaimer: This is my analysis and does not constitute financial advice For more analysis like this ON DEMAND please leave me a message. Shortby WavesInvesting0
PFE - SEL strategyThe sell strategy so far working well. I think we may add to the position $ 57-59 range. Profit target now $ 47.75 (adjusted). Stop loss changed to $ 61. Shortby peterbokmaUpdated 553
$PFE - From hard on pills to covid. A story of corruptionIt is not really a story of corruption. It is crazy that the two most successful times in this company's career was by creating Viagra and creating Covid...errrr I mean the vaccine for one of the covid strands....sometimes...when it works. Screw it though!!! The government is giving them billions and billions of dollars for no reason!!! Let the good time roll baby!! I think she will retest the breakout and then continue higher for as long as a democrat is president. I mean covid exists. Dang it....you know what I mean. As long as the US government funnels them billions unnecessarily. I cant stand the CEO and he should be in jail. I choose to be in MRK or many others instead. Not that they are really much better, but PFE CEO is truly an evil person. Good luck to you crazy people who stick with it. This is not a recommendation to buy or sell. It is for informational purposes only.by UnknownUnicorn16739272222
3 analysis shows that might be the end of corrective wave harmonic pattern with good cluster of fibonnaci price hidden divergence good luckLongby HUNTMARKET1
PfizerLets see if price can fill the gap waiting for price to test the lower boundary and volume spikes Longby ChiranjeevChhabra0
Pfizer RSI bearish divergenceon weekly we can see bearish divergence on RSI. there is also possible h&s forming. we have also fundemantals about rigged vaccine trials for emergency authorization acceptance, vaccine deaths piling up and big shareholders of Pfizer dumping their stock. sell now! first profit target 32$ second profit target 1$Shortby p1ng0
PFE1Y RSI is at a top. MFI is topping. 5Y RSI is trending up. MFI is trending down. ALL RSI topped. MFI is topping. www.conservativebeaver.com Prediction: The indicators don't look good for too much more upside, but this article sure will drop the stock soon. Falling. There is also a gap at $15. For my educational purpose, not to be used as financial advice.Shortby Kyo026Updated 1
Pfizer: Ready to Shoot Lower? Pfizer - Short Term - We look to Sell at 49.33 (stop at 51.54) The trend of lower highs is located at 53.50. Previous support located at 50.00. A move through bespoke support at 50.00 and we look for extended losses. Closed below the 20-day EMA. The medium term bias remains bearish. Our profit targets will be 43.51 and 41.00 Resistance: 54.00 / 57.00 / 60.00 Support: 50.00 / 45.00 / 40.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses. Shortby Saxo228
$PFE - Sitting on the neck line... In my previous chart I was leaning on head and shoulder not playing out. But now with war about to break out in Ukraine, I am not so sure that the neckline area of $50.25 will hold. We have been on an uptrend that started since March 2021 and has checked back to the trend line once before. If we were to check back to the trend line again after the head and shoulder neckline breaks, it could close the gap at $45.99. I will be watching $50.25 - $49 area to see if that support can hold. If it breaks, the bear case will play out and we can see $45.99. Bear Target 1 - $45.99 Neckline - $50.25 Bull case - bounce from neck line and move towards $62. ——————————————————— How to read my charts? - Matching color trend lines shows the pattern. Sometimes a chart can have multiple patterns. Each pattern will have matching color trend lines. - The yellow horizontal lines show support and resistance areas. - Fib lines also show support and resistance areas. - The dotted white lines show the price projection for breakout or breakdown target. Disclaimer: Not investment advice.Longby PaperBozz115
Pfizer - PFE - is this the end of Pfizer?I guess Pfizer's stock price could help us with knowing when this Covid nightmare might be drawing to a close. This count suggests that we might be about to begin a 5th of a 5th of a 5th. If this count has any merit and the trend does end then we can expect some serious downside to this stock some time in the not too distant future. (A more bearish count could be made for a completed 5th wave already taking place and I show that with the blue count, but the red count is my preferred count.)Longby tomj24173
Time to buy!Price hit the support again and is bouncing up ! In my opinion a position can be initiated at this level ! Maybe half position now and the second half either on a break of the down trend line or either at the lower support in case the current support breaks ! The dividend is also good ! Just my view :)Longby Bleck0
PFE Long from 50.44 levelpfe had a earing report this week. price respected the 50.44 level. would look for buy opportunities. Longby olakunledean1
Pfizer Analysis 08.02.2022Hello Traders, welcome to this free and educational analysis. I am going to explain where I think this asset is going to go over the next few days and weeks and where I would look for trading opportunities. If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below. I will personally reply to every single comment! If you enjoyed this analysis, I would definitely appreciate it, if you smash that like button and maybe consider following my channel. Thank you for watching and I will see you tomorrow!04:08by basictradingtv101062
Pfizer - Might get worse! 😨-The reason why PFE is dropping is not the economical situation but rather the COVID situation which is getting lighter (at least in folk's mind) every day. -We got omicron but it being a light virus almost like a flu also didn't catch much attention lately. -This stock throughout the pandemic depended on negative news, whoever is chaos oriented invested in this company, but lets all agree that the better the health situation gets and less of a tragedy COVID becomes, the less attention will be on this stock. -Not to say that the company is worthless now but it wont have the hype it had for sure! -Earnings are forecasted to decline on average of 6.2% per year. OUR TARGET PRICE: $45-$50by caldooninvestment222
$PFE Key levels, Analysis & Targets$PFE Key levels, Analysis & Targets From the analysis of the trend of chart, there is a chance that this can happen in both cases.by Mr_12Tails4
Pfizer AnalysisIt seems Pfizer is losing a bullish trend. It could continue its downward trajectoryShortby abmajid911
Pfizer, and why you keep old notesI got an alert on Pfizer NYSE:PFE just now that on the 30m a Tradingview Spike Alert I had setup fired. This is following research I did over the weekend to the Support level that PFE reached in the recent down move. While doing that I found an old annotation from November 2020 earnings that informed a long term dividend investment play. It's nice to see how something has performed over the long term to remind an investor to buy and hold good companies. The company has earnings tomorrow.by norok118
$PFE - Downtrend Reversal - 4 Day Inside Bar - Upcoming CatalystNYSE:PFE A hammer signaled reversal for $PFE. Shortly after price broke out of the downtrend resistance. Four inside bars have formed during period of consolidation. $PFE looks primed for sharp movement. Catalyst would likely be FDA / CDC approval/rejection of its Covid vaccination for children, expected in 4th week of Feb. Application is for 2 doses, though 3 would be required. Application and study for 3rd shot are expected to be submitted during the initial application review phase. This is one ticker to be aware of. Biased long, but willing to play both sides.Longby TheGritz1